Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#71 / 100 Total
L - Loews Corp. - Stock Price Chart
TickerL [NYSE, S&P 500]
CompanyLoews Corp.
CountryUSA
IndustryInsurance - Property & Casualty
Market Cap17.09BEPS (ttm)6.73
P/E11.47EPS this Y-
Forward P/E-EPS next Y-
PEG0.82EPS past 5Y25.93%
P/S1.05EPS next 5Y14.03%
P/B1.06EPS Q/Q27.79%
Dividend0.32%Sales Q/Q11.84%
Insider Own17.31%Inst Own59.46%
Insider Trans-1.87%Inst Trans-3.46%
Short Float0.99%EarningsMay 06/b
Analyst Recom3.00Target Price52.00
Avg Volume712.32K52W Range55.94 - 78.55
Loews Corp. is a holding company, which engages in the business of commercial property and casualty insurance, transportation and storage of natural gas and natural gas liquids, and operation of a chain of hotels. It operates through the following segments: CNA Financial, Boardwalk Pipelines, Loews Hotels and Co, and Corporate. The CNA Financial segment is involved in the sale of property and casualty insurance products and services, including surety, primarily through a network of independent agents, brokers, and managing general underwriters. The Boardwalk Pipelines segment focuses on midstream portion of the natural gas and NGLs industry, providing transportation, and storage for those commodities. The Loews Hotels and Co segment refers to a chain of hotels, which are in the United States and one of which is in Canada. The Corporate segment consists of investment income from the parent company's cash and investments, parent company interest expense, and other unallocated parent company expenses. The company was founded by Laurence A. Tisch and Preston Robert Tisch on November 12, 1969 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TISCH JONATHAN MCo-Ch. of Bd/Off. of the Pres.May 16 '24Sale77.1450,0003,857,000457,799May 16 05:03 PM
TISCH JONATHAN MCo-Ch. of Bd/Off. of the Pres.May 14 '24Sale77.2450,0003,862,000507,799May 16 05:03 PM
TISCH ANDREW HDirectorMay 09 '24Option Exercise0.001,70601,726,479May 09 08:32 AM
BERMAN ANN EDirectorMay 09 '24Option Exercise0.001,70604,998May 09 08:34 AM
DAVIDSON CHARLES DDirectorMay 09 '24Option Exercise0.001,706026,906May 09 08:35 AM
ALTI - AlTi Global Inc - Stock Price Chart
TickerALTI [NASD, RUT]
CompanyAlTi Global Inc
CountryUSA
IndustryAsset Management
Market Cap326.42MEPS (ttm)-1.52
P/E-EPS this Y110.81%
Forward P/E8.99EPS next Y68.42%
PEG-EPS past 5Y-
P/S1.34EPS next 5Y-
P/B0.82EPS Q/Q120.38%
Dividend-Sales Q/Q-12.46%
Insider Own53.38%Inst Own9.13%
Insider Trans0.27%Inst Trans0.10%
Short Float2.26%EarningsMay 10/b
Analyst Recom1.00Target Price9.00
Avg Volume137.73K52W Range4.07 - 9.22
AlTi Global, Inc. is a financial services company, which engages in the provision of investment, advisory, and administrative services. The company was founded on December 18, 2020 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Keaney Timothy FPresident, Asset ManagementMay 16 '24Buy4.6016,41775,51897,321May 16 09:34 PM
Keaney Timothy FPresident, Asset ManagementMay 15 '24Buy4.5250,195226,88180,904May 16 09:34 PM
Keaney Timothy FPresident, Asset ManagementMay 14 '24Buy4.6217,59881,30330,709May 16 09:34 PM
Moran Kevin P.See RemarksMay 14 '24Sale4.705912,778175,184May 16 05:03 PM
ilWaddi Cayman Holdings10% OwnerApr 03 '24Buy4.9920,00099,80017,933,265Apr 04 04:15 PM
ANIP - ANI Pharmaceuticals Inc - Stock Price Chart
TickerANIP [NASD, RUT]
CompanyANI Pharmaceuticals Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap1.34BEPS (ttm)1.69
P/E37.75EPS this Y-4.76%
Forward P/E12.78EPS next Y11.19%
PEG17.16EPS past 5Y-6.27%
P/S2.58EPS next 5Y2.20%
P/B2.96EPS Q/Q1220.00%
Dividend-Sales Q/Q28.70%
Insider Own18.23%Inst Own69.66%
Insider Trans-9.05%Inst Trans2.76%
Short Float1.34%EarningsMay 10/b
Analyst Recom1.40Target Price81.60
Avg Volume159.29K52W Range40.55 - 70.81
ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. The Generics, Established Brands, and Other segment consists of contract manufactured products, development services, royalties, and other. The Rare Disease segment involves the operations related to Cortrophin Gel. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lalwani NikhilPRESIDENT & CEOMay 14 '24Sale66.1016,6691,101,821377,505May 16 05:02 PM
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.May 13 '24Sale67.6925016,92259,481May 13 05:25 PM
Gassert ChadSVP - CORP. DEV. & STRATEGYMay 01 '24Sale66.6220,0001,332,400233,226May 03 05:48 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSApr 19 '24Sale65.1716,8091,095,443782,620Apr 22 06:26 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSApr 18 '24Sale64.9810,423677,287799,429Apr 22 06:26 PM
VTR - Ventas Inc - Stock Price Chart
TickerVTR [NYSE, S&P 500]
CompanyVentas Inc
CountryUSA
IndustryREIT - Healthcare Facilities
Market Cap19.72BEPS (ttm)-0.18
P/E-EPS this Y-155.00%
Forward P/E-EPS next Y97.06%
PEG-EPS past 5Y-
P/S4.27EPS next 5Y-
P/B2.10EPS Q/Q-181.80%
Dividend3.73%Sales Q/Q11.39%
Insider Own0.44%Inst Own95.30%
Insider Trans-1.94%Inst Trans-0.57%
Short Float1.90%EarningsMay 01/a
Analyst Recom1.63Target Price52.06
Avg Volume2.38M52W Range39.33 - 50.99
Ventas, Inc. engages in the acquisition and ownership of seniors housing and healthcare properties. It operates through the following segments: Triple-Net Leased Properties, Senior Housing Operating Portfolio (SHOP), and Office Operations. The Triple-Net Leased Properties segment invests in and owns senior housing and healthcare properties. The SHOP segment invests in senior housing communities and engages with independent managers to operate those communities. The Office Operations segment acquires, owns, develops, leases, and manages medical office buildings and life science, research, and innovation centers. The company was founded in 1983 and is headquartered in Chicago, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RAKOWICH WALTER CDirectorMay 15 '24Sale48.402,145103,81426,031May 16 05:01 PM
Liebbe Gregory RSVP, Chief Accounting OfficerMay 10 '24Sale47.7014,625697,65312,524May 13 05:01 PM
Probst Robert FEVP and CFOMay 07 '24Sale47.1118,500871,552176,403May 08 06:06 PM
RAKOWICH WALTER CDirectorMay 26 '23Sale42.571,24252,87024,528May 30 05:01 PM
PET - Wag Group Co - Stock Price Chart
TickerPET [NASD]
CompanyWag Group Co
CountryUSA
IndustrySoftware - Application
Market Cap82.46MEPS (ttm)-0.35
P/E-EPS this Y31.43%
Forward P/E-EPS next Y78.33%
PEG-EPS past 5Y-
P/S0.95EPS next 5Y-
P/B-EPS Q/Q-3.52%
Dividend-Sales Q/Q12.59%
Insider Own52.22%Inst Own5.81%
Insider Trans-3.38%Inst Trans79.11%
Short Float0.07%EarningsMay 09/b
Analyst Recom1.00Target Price5.40
Avg Volume74.67K52W Range1.59 - 2.65
Wag! Group Co. engages in the development of a proprietary marketplace technology, which enables independent pet caregivers to connect with pet parents for specific pet care services. The company was founded in 2015 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Allread DylanChief Operating OfficerMay 16 '24Option Exercise0.099,022812668,281May 16 05:01 PM
Allread DylanChief Operating OfficerMay 16 '24Sale2.049,02218,405659,259May 16 05:01 PM
Allread DylanChief Operating OfficerMay 15 '24Option Exercise0.0910,383934669,642May 16 05:01 PM
Allread DylanChief Operating OfficerMay 15 '24Sale2.1210,38322,012659,259May 16 05:01 PM
Allread DylanChief Operating OfficerMay 14 '24Option Exercise0.0910,058905669,317May 14 05:50 PM
NTCT - Netscout Systems Inc - Stock Price Chart
TickerNTCT [NASD, RUT]
CompanyNetscout Systems Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap1.49BEPS (ttm)-2.08
P/E-EPS this Y-3.64%
Forward P/E9.61EPS next Y2.83%
PEG-EPS past 5Y-17.25%
P/S1.79EPS next 5Y1.78%
P/B0.78EPS Q/Q-905.74%
Dividend-Sales Q/Q-2.23%
Insider Own3.63%Inst Own92.74%
Insider Trans-0.69%Inst Trans-1.29%
Short Float2.73%EarningsMay 09/b
Analyst Recom3.00Target Price31.00
Avg Volume630.41K52W Range18.60 - 31.66
NetScout Systems, Inc. engages in the provision of application and network performance management solutions. It operates through the following geographical segments: the United States, Europe, Asia, and Rest of the World. The company was founded by Anil K. Singhal and Narendra Popat in 1984 and is headquartered in Westford, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SZABADOS MICHAELChief Operating OfficerMay 14 '24Sale20.415,000102,05521,084May 16 05:00 PM
DOWNING JOHNEVP, World-Wide SalesFeb 16 '24Sale21.933,00065,790111,115Feb 20 05:00 PM
SZABADOS MICHAELChief Operating OfficerJan 30 '24Sale22.135,000110,66426,084Jan 31 04:15 PM
SZABADOS MICHAELChief Operating OfficerDec 07 '23Sale21.045,000105,17931,084Dec 11 04:30 PM
DOWNING JOHNEVP, World-Wide SalesNov 10 '23Sale20.213,00060,630114,115Nov 14 04:30 PM
RCL - Royal Caribbean Group - Stock Price Chart
TickerRCL [NYSE, S&P 500]
CompanyRoyal Caribbean Group
CountryUSA
IndustryTravel Services
Market Cap36.77BEPS (ttm)7.63
P/E18.73EPS this Y61.82%
Forward P/E11.26EPS next Y15.79%
PEG0.63EPS past 5Y-6.87%
P/S2.49EPS next 5Y29.90%
P/B7.14EPS Q/Q783.25%
Dividend-Sales Q/Q29.21%
Insider Own8.12%Inst Own81.26%
Insider Trans-5.12%Inst Trans1.72%
Short Float6.72%EarningsApr 25/b
Analyst Recom1.58Target Price162.31
Avg Volume2.68M52W Range75.62 - 143.93
Royal Caribbean Group is a cruise company, which engages in the ownership and operation of the following global cruise brands: Royal Caribbean International, Celebrity Cruises, and Silversea Cruises. The firm also holds interest in TUI Cruises GmbH, which operates the German brands TUI Cruises and Hapag-Lloyd Cruises. The company was founded by Arne Wilhelmsen in 1968 and is headquartered in Miami, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bayley Michael WPres&CEO, Royal Caribbean IntlMay 15 '24Sale140.2124,2013,393,22298,850May 16 04:57 PM
Pujol Henry LChief Accounting OfficerApr 30 '24Sale141.239,9441,404,39116,687May 02 04:39 PM
Liberty Jason TPresident & CEOApr 26 '24Sale139.6350,0006,981,335153,017Apr 26 06:19 PM
Bayley Michael WPres&CEO, Royal Caribbean IntlFeb 13 '24Sale116.0111,7531,363,486166,537Feb 15 04:48 PM
Wilhelmsen Arne AlexanderDirectorDec 14 '23Sale121.73284,76634,664,56519,167,507Dec 14 06:02 PM
NBIX - Neurocrine Biosciences, Inc. - Stock Price Chart
TickerNBIX [NASD]
CompanyNeurocrine Biosciences, Inc.
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap14.28BEPS (ttm)3.64
P/E39.01EPS this Y80.36%
Forward P/E21.12EPS next Y50.85%
PEG2.17EPS past 5Y62.04%
P/S7.21EPS next 5Y18.00%
P/B5.98EPS Q/Q153.10%
Dividend-Sales Q/Q22.57%
Insider Own2.54%Inst Own93.18%
Insider Trans-24.14%Inst Trans-1.46%
Short Float1.86%EarningsMay 01/b
Analyst Recom1.66Target Price159.25
Avg Volume849.64K52W Range89.04 - 148.37
May-16-24 04:47PM Neurocrine Biosciences Insider Sold Shares Worth $4,138,436, According to a Recent SEC Filing (MT Newswires)
May-14-24 08:30AM Neurocrine Biosciences Presented Baseline Data from the CAHtalyst Program in CAH and Study Data for Modified-Release Hydrocortisone in Primary Adrenal Insufficiency and CAH at ECE 2024 (PR Newswire)
May-09-24 11:51AM How Neurocrine, An IBD 50 Stock, Is Stacking Up Wins In 2024 And Outperforming Peers (Investor's Business Daily)
11:51AM How Neurocrine Is Stacking Up Wins In 2024 And Outperforming Peers (Investor's Business Daily)
09:45AM Neurocrine Biosciences Presents CAHtalyst Adult Study Baseline Characteristics and Data on Impact of Supraphysiologic Glucocorticoid Therapy at AACE 2024 (PR Newswire)
08:30AM Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1076986 in Healthy Adults (PR Newswire)
02:35AM Nxera Pharma's partner Neurocrine Biosciences Initiates Phase 1 Clinical Study Evaluating Effects of NBI-1117567 in Healthy Adults (GlobeNewswire)
May-08-24 08:30AM Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1117567 in Healthy Adults (PR Newswire)
May-07-24 04:15PM Neurocrine Biosciences to Present at the BofA Securities 2024 Health Care Conference (PR Newswire)
08:30AM Neurocrine Biosciences to Present Phase 3 Baseline Characteristics Data from the CAHtalyst Program of Crinecerfont in CAH, and Data for Modified-Release Hydrocortisone in Primary Adrenal Insufficiency and CAH Studies at ECE 2024 (PR Newswire)
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ABERNETHY MATTChief Financial OfficerMay 15 '24Option Exercise73.6015,0001,104,00046,528May 16 04:40 PM
ABERNETHY MATTChief Financial OfficerMay 15 '24Sale140.2415,0002,103,60931,528May 16 04:40 PM
ABERNETHY MATTChief Financial OfficerMay 14 '24Option Exercise73.6015,0001,104,00046,528May 16 04:40 PM
LYONS GARY ADirectorMay 14 '24Option Exercise42.7612,500534,500129,447May 16 04:55 PM
ABERNETHY MATTChief Financial OfficerMay 14 '24Sale135.6615,0002,034,82631,528May 16 04:40 PM
CRM - Salesforce Inc - Stock Price Chart
TickerCRM [NYSE, DJIA, S&P 500]
CompanySalesforce Inc
CountryUSA
IndustrySoftware - Application
Market Cap276.22BEPS (ttm)4.21
P/E67.70EPS this Y19.16%
Forward P/E25.71EPS next Y13.04%
PEG4.17EPS past 5Y24.06%
P/S7.92EPS next 5Y16.22%
P/B4.63EPS Q/Q1576.91%
Dividend0.12%Sales Q/Q10.77%
Insider Own3.06%Inst Own82.51%
Insider Trans-10.16%Inst Trans-0.97%
Short Float0.88%EarningsMay 29/a
Analyst Recom1.66Target Price336.93
Avg Volume5.62M52W Range193.68 - 318.71
Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Millham BrianPresident and COOMay 15 '24Option Exercise218.212,106459,5502,106May 16 04:53 PM
Benioff MarcChair and CEOMay 15 '24Sale284.7315,0004,270,88112,557,327May 16 04:45 PM
Millham BrianPresident and COOMay 15 '24Sale280.002,106589,6800May 16 04:53 PM
Harris ParkerCo-Founder and CTO, SlackMay 14 '24Option Exercise118.044,200495,768119,962May 15 04:37 PM
Benioff MarcChair and CEOMay 14 '24Sale276.8515,0004,152,69812,572,327May 15 04:51 PM
ZLAB - Zai Lab Limited ADR - Stock Price Chart
TickerZLAB [NASD]
CompanyZai Lab Limited ADR
CountryChina
IndustryBiotechnology
Market Cap1.97BEPS (ttm)-3.50
P/E-EPS this Y13.82%
Forward P/E-EPS next Y55.97%
PEG-EPS past 5Y-16.93%
P/S6.76EPS next 5Y-
P/B2.55EPS Q/Q-7.51%
Dividend-Sales Q/Q38.78%
Insider Own0.54%Inst Own42.51%
Insider Trans-11.16%Inst Trans-1.97%
Short Float4.44%EarningsMay 08/a
Analyst Recom1.15Target Price51.82
Avg Volume647.22K52W Range13.48 - 37.92
Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra. The company was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Edmondson Frazor Titus IIIChief Legal OfficerMay 14 '24Sale21.3310,000213,34616,408May 16 04:52 PM
Smiley Joshua LSee RemarksMay 13 '24Buy21.403,00064,20031,684May 15 04:03 PM
Reinhart HaraldSee RemarksApr 04 '24Sale15.672,10532,99251,800Apr 05 05:48 PM
Smiley Joshua LSee RemarksApr 04 '24Sale15.671,98831,15828,684Apr 05 05:48 PM
Amado RafaelSee RemarksApr 04 '24Sale15.671,95230,59423,532Apr 05 05:47 PM
12345678910